☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Neutropenia
BeyondSpring Presents Results of Plinabulin in P-III PROTECTIVE-1 Study for Prevention of Chemotherapy-Induced Neutropenia at ASCO...
June 11, 2021
Sandoz's Ziextenzo (pegfilgrastim) Receives EU Approval for Reduction in Duration of Neutropenia
November 27, 2018
Mundipharma Receives EU Approval for Pelmeg (Pegfilgrastim- Biosimilar)
November 24, 2018
Biocon and Mylan Fulphila (pegfilgrastim- Neulasta biosimilar) Receives CHMP (EMA) Recommendation for Neutropenia
November 21, 2018
Pfizer's Nivestym (filgrastim-aafi- biosmilar) Receives the US FDA Approval for Neutropenia
July 20, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.